Webinar: Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen’s Renmice-Based Platform
Our webinar “Overcoming Difficulties In GPCR Antibody Discovery Using Biocytogen's Renmice-Based Platform" was live at 11:00 AM EDT on Aug 30th, 2023. About the Webinar GPCRs…
Read more
Join us at the 11th Annual Immuno-Oncology Summit: Aug 7-9
Join us at the 11th Annual Immuno-Oncology Summit from August 7-9 in Boston! Learn more about our in vivo efficacy, PK/PD, toxicity, and in vitro…
Read more
Join us at Basic Cardiovascular Sciences Scientific Sessions 2023: July 31–August 3
Join us at the Basic Cardiovascular Science Event from July 31-August 3 in Boston! Learn more about how our gene editing services and animal models…
Read more
Meet us at BIO Asia-Taiwan!
Biocytogen’s Asia-Pacific business development team is pleased to host online 1-on-1 meetings at BIO Asia-Taiwan, taking place from July 25-26, 2023! Chat with our team…
Read more
The Key Technology Of Biocytogen’s Fully Human Antibody Renmab Platform Has Been Granted A Chinese Patent
Beijing, China, July 11, 2023 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced its independently developed key technology of RenMabTM platform has been…
Read more
Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC Beijing, China and London, UK, July 5, 2023 - Biocytogen Pharmaceuticals (Beijing) Co.,…
Read more
Webinar: Bispecific Antibody-Drug Conjugates (BsADCs): An Emerging, Promising Anti-Cancer Therapeutic Modality With Improved Efficacy And Safety
Our webinar “Bispecific Antibody-Drug Conjugates (BsADCs): An Emerging, Promising Anti-Cancer Therapeutic Modality With Improved Efficacy And Safety" was live at 12:00 PM EDT on July…
Read more
Join us at Chinese American Diabetes Association 2023 Annual Meeting: June 20-23
Join us at the Chinese American Diabetes Association 2023 Annual Meeting in San Diego, CA from June 20-23! Learn more about our custom model generation…
Read more
Visit Our Bispecific ADC Poster at IO Summit Europe 2023!
Visit Our Bispecific ADC Poster at IO Summit Europe 2023! Biocytogen’s antibody Business Development & Licensing team is excited to attend the upcoming Immuno-Oncology Summit…
Read more
Join us at the 6th Annual Next-Gen Immuno-Oncology: June 22-23
Join us in our presentation and meet with our team if you are also attending 6th Annual Next-Gen Immuno-Oncology from June 22-23 in Boston! Learn…
Read more